EC
RCUS icon

EcoR1 Capital’s Arcus Biosciences RCUS Stock Holding History

EcoR1 Capital’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,265,101
Closed -$103M – 92
2022
Q1 		$103M Sell
3,265,101
-2,258,257
-41% -$75.7M 3.22% 10
2021
Q4 		$224M Buy
5,523,358
+400,999
+8% +$15.6M 7.12% 3
2021
Q3 		$179M Buy
5,122,359
+1,787,112
+54% +$55.6M 6.21% 4
2021
Q2 		$91.6M Buy
3,335,247
+1,139,355
+52% +$32.5M 3.42% 8
2021
Q1 		$61.7M Hold
2,195,892
– – 2.73% 13
2020
Q4 		$57M Buy
2,195,892
+385,892
+21% +$9.34M 3.06% 13
2020
Q3 		$31M Hold
1,810,000
– – 2.21% 18
2020
Q2 		$44.8M Buy
1,810,000
+1,517,900
+520% +$41M 3.31% 11
2020
Q1 		$4.05M Sell
292,100
-437,805
-60% -$5.44M 0.42% 35
2019
Q4 		$7.37M Sell
729,905
-24,600
-3% -$207K 0.66% 29
2019
Q3 		$6.87M Sell
754,505
-733,700
-49% -$5.9M 0.87% 22
2019
Q2 		$11.8M Buy
1,488,205
+498,059
+50% +$4.99M 1.19% 20
2019
Q1 		$12.4M Sell
990,146
-233,349
-19% -$2.53M 1.14% 24
2018
Q4 		$13.2M Sell
1,223,495
-1,012,892
-45% -$11.8M 1.32% 24
2018
Q3 		$31.2M Hold
2,236,387
– – 2.81% 10
2018
Q2 		$27.4M Hold
2,236,387
– – 2.61% 12
2018
Q1 		$34.5M Buy
+2,236,387
New +$37.3M 3.46% 10

Other funds holding RCUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

EcoR1 Capital's RCUS Position: Q2 2022 in Review

EcoR1 Capital sold out of Arcus Biosciences (RCUS) in Q2 2022, closing a stake of 3,265,101 shares — an estimated $103M sold.

EcoR1 Capital first reported a position in RCUS in Q1 2018 and held it in 17 quarters. The position peaked at $224M in Q4 2021. 173 funds tracked by Wall St. Rank hold RCUS as of Q2 2022.

  • EcoR1 Capital reported no remaining Arcus Biosciences position as of Q2 2022 after selling out during the quarter.
  • EcoR1 Capital sold 3,265,101 Arcus Biosciences shares in Q2 2022, an estimated $103M.
  • EcoR1 Capital first reported a position in Arcus Biosciences in Q1 2018 and held it in 17 quarters.
  • EcoR1 Capital's Arcus Biosciences position peaked at $224M in Q4 2021.
  • 173 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2022.

Based on EcoR1 Capital's 13F filing for Q2 2022, filed 15 Aug 2022.